本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ascendis Pharma A/S

161.52
+7.094.59%
盤前162.521.00+0.62%08:33 EDT
成交量:49.56萬
成交額:7,907.69萬
市值:97.52億
市盈率:-25.66
高:162.30
開:155.20
低:154.64
收:154.43
資料載入中...
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/02

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities